TABLE 1.
HLA types, tetramer reactivity, and clinical data of study participants
| Identification no. | HLA type | Tetramer reactivitya | Clinical statusb | CD4 countc | Viral loadd |
|---|---|---|---|---|---|
| 1 | A1, A3, B8, B53 | B8p24, B8nef | HIV-1+ | 270 | 18,646 |
| 2 | A2, A3, B57, B40 | A2p17, A2pol, A3p17, A2EBV, A2CMV | HIV-1+ | 129 | 66,752 |
| 3 | A2, A3, B27, B37 | A2p17, A2pol, A2EBV, A2CMV | HIV-1+ | 459 | 939 |
| 4 | A2, A33, B15, B42 | A2p17 | HIV-1+ | 1,029 | 101 |
| 5 | A2, B27, B13 | A2p17, A2pol, A2EBV, A2CMV | HIV-1+ | 990 | 23,737 |
| 6 | A3, A31, B13, B51 | A3p17, A3pol | HIV-1+ | 453 | 22,580 |
| 7 | A3, A24, B27, B15 | A3p17, A3pol | HIV-1+ | 385 | 24,968 |
| 8 | A2 | A2CMV | HIV-1− | ||
| 9 | A2, B8 | A2EBV, B8EBV | HIV-1− | ||
| 10 | A2, A31, B15, B44 | A2CMV | HIV-1− | ||
| 11 | A2, A24, B44, B7 | A2EBV, A2CMV | HIV-1− | ||
| 12 | A2 | A2CMV | HIV-1− | ||
| 13 | A1, A2, B8, B56 | A2CMV | HIV-1− | ||
| 14 | A1, A11, B8, B15 | B8EBV | HIV-1− | ||
| 15 | A1, A2, B18, B51 | A2EBV, A2CMV | HIV-1− | ||
| 16 | A2, A23, B13, B44 | A2CMV | HIV-1− | ||
| 17 | A2, A23, A39, B41 | A2CMV | HIV-1− | ||
| 18 | A2, A24, A44, A15 | A2CMV | HIV-1− |
a
Each tetramer is designated by the HLA type and the antigen.
b
Clinical status of study participants at the time of their blood draw. HIV-1+ and HIV-1− indicate HIV-1-infected and uninfected individuals, respectively.
c
CD4 count indicates a number of CD4+ T cells per milliliter of blood.
d
Viral load indicates a number of HIV-1 viral genomes per milliliter of a serum sample.